The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
Open accessAbstract
CD36/FAT (fatty acid translocase) is associated with human and murine nonalcoholic fatty liver disease, but it has been unclear whether it is simply a marker or whether it directly contributes to disease pathogenesis. Mice with hepatocyte-specific deletion of Janus kinase 2 (JAK2L mice) have increased circulating free fatty acids (FAs), dramatically increased hepatic CD36 expression and profound fatty liver. To investigate the role of elevated CD36 in the development of fatty liver, we studied two models of hepatic steatosis, a genetic model (JAK2L mice) and a high-fat diet (HFD)-induced steatosis model. We deleted Cd36 specifically in hepatocytes of JAK2L mice to generate double knockouts and from wild-type mice to generate CD36L single-knockout mice. Hepatic Cd36 disruption in JAK2L livers significantly improved steatosis by lowering triglyceride, diacylglycerol, and cholesterol ester content. The largest differences in liver triglycerides were in species comprised of oleic acid (C18:1). Reduction in liver lipids correlated with an improvement in the inflammatory markers that were elevated in JAK2L mice, namely aspartate aminotransferase and alanine transaminase. Cd36 deletion in mice on HFD (CD36L-HFD) reduced liver lipid content and decreased hepatic 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-FA uptake as compared with CON-HFD. Additionally, CD36L-HFD mice had improved whole-body insulin sensitivity and reduced liver and serum inflammatory markers. Therefore, CD36 directly contributes to development of fatty liver under conditions of elevated free FAs by modulating the rate of FA uptake by hepatocytes. In HFD-fed animals, disruption of hepatic Cd36 protects against associated systemic inflammation and insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism
Febbraio, M., Abumrad, N. A., Hajjar, D. P., Sharma, K., Cheng, W., Pearce, S. F. A., & Silverstein, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19055 · Cited by 769
Self-citationCoburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
Self-citationHepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
Zhou, J., Febbraio, M., Wada, T., Zhai, Y., Kuruba, R., He, J., Lee, J. H., Khadem, S., Ren, S., Li, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.037 · Cited by 605
Self-citationIncreased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity
Koonen, D. P. Y., Jacobs, R. L., Febbraio, M., Young, M. E., Soltys, C.-L. M., Ong, H., Vance, D. E., & Dyck, J. R. B. (2007) · Diabetes · doi:10.2337/db07-0907 · Cited by 511
Self-citationSamuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497
Miquilena-Colina, M. E., Lima-Cabello, E., Sánchez-Campos, S., García-Mediavilla, M. V., Fernández-Bermejo, M., Lozano-Rodríguez, T., Vargas-Castrillón, J., Buqué, X., Ochoa, B., Aspichueta, P., et al. (2011) · Gut · doi:10.1136/gut.2010.222844 · Cited by 451
Savage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447
Gene expression in human NAFLD
Greco, D., Kotronen, A., Westerbacka, J., Puig, O., Arkkila, P., Kiviluoto, T., Laitinen, S., Kolak, M., Fisher, R. M., Hamsten, A., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00074.2008 · Cited by 427
Cellular fatty acid uptake: a pathway under construction
Su, X., & Abumrad, N. A. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.11.001 · Cited by 407
Ibrahimi, A., Bonen, A., Blinn, W. D., Hajri, T., Li, X., Zhong, K., Cameron, R., & Abumrad, N. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26761 · Cited by 370
Newberry, E. P., Xie, Y., Kennedy, S., Han, X., Buhman, K. K., Luo, J., Gross, R. W., & Davidson, N. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309377200 · Cited by 303
Doege, H., Baillie, R. A., Ortegon, A. M., Tsang, B., Wu, Q., Punreddy, S., Hirsch, D., Watson, N., Gimeno, R. E., & Stahl, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.006 · Cited by 279
Hajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14596 · Cited by 276
Fan, Y., Menon, R. K., Cohen, P., Hwang, D., Clemens, T., DiGirolamo, D. J., Kopchick, J. J., Le Roith, D., Trucco, M., & Sperling, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014308 · Cited by 255
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice
Yakar, S., Setser, J., Zhao, H., Stannard, B., Haluzik, M., Glatt, V., Bouxsein, M. L., Kopchick, J. J., & LeRoith, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17763 · Cited by 252
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Hajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214596 · Cited by 231
Cui, Y., Hosui, A., Sun, R., Shen, K., Gavrilova, O., Chen, W., Cam, M. C., Gao, B., Robinson, G. W., & Hennighausen, L. (2007) · Hepatology · doi:10.1002/hep.21713 · Cited by 183
Goudriaan, J. R., Dahlmans, V. E. H., Teusink, B., Ouwens, D. M., Febbraio, M., Maassen, J. A., Romijn, J. A., Havekes, L. M., & Voshol, P. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300143-jlr200 · Cited by 182
Self-citationSynthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Ma, Y., Huang, Y., Yan, L., Gao, M., & Liu, D. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-0986-7 · Cited by 165
Bieghs, V., Wouters, K., van Gorp, P. J., Gijbels, M. J. J., de Winther, M. P. J., Binder, C. J., Lütjohann, D., Febbraio, M., Moore, K. J., van Bilsen, M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.051 · Cited by 160
Self-citationSos, B. C., Harris, C. A., Nordstrom, S. M., Tran, J. L., Balázs, M., Caplazi, P., Febbraio, M., Applegate, M. A. B., Wagner, K., & Weiss, E. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42894 · Cited by 143
Self-citationKrammer, J., Digel, M., Ehehalt, F., Stremmel, W., Füllekrug, J., & Ehehalt, R. (2011) · International Journal of Medical Sciences · doi:10.7150/ijms.8.599 · Cited by 136
Role of CD36 in Membrane Transport and Utilization of Long-Chain Fatty Acids by Different Tissues
Coburn, C. T., Hajri, T., Ibrahimi, A., & Abumrad, N. A. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:2-3:117 · Cited by 130
Bechmann, L. P., Gieseler, R. K. H., Sowa, J., Kahraman, A., ERHARD, J., Wedemeyer, I., Emons, B., Jochum, C., Feldkamp, T., Gerken, G., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02248.x · Cited by 127
Ichikawa, T., Hamasaki, K., Ishikawa, H., Ejima, E., Eguchi, K., & Nakao, K. (2003) · Gut · doi:10.1136/gut.52.6.914 · Cited by 119
Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids
Khalifeh‐Soltani, A., McKleroy, W., Sakuma, S., Cheung, Y. Y., Tharp, K. M., Qiu, Y., Turner, S., Chawla, A., Stahl, A., & Atabai, K. (2014) · Nature Medicine · doi:10.1038/nm.3450 · Cited by 116
Nassir, F., Okunade, A. L., Brunt, E. M., & Abumrad, N. A. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037812 · Cited by 115
The genetic architecture of NAFLD among inbred strains of mice
Hui, S. T. Y., Parks, B. W., Org, E., Norheim, F., Che, N., Pan, C., Castellani, L. W., Charugundla, S., Dirks, D. L., Psychogios, N., et al. (2015) · eLife · doi:10.7554/elife.05607 · Cited by 113
Steneberg, P., Sykaras, A. G., Backlund, F., Straseviçiene, J., Söderström, I., & Edlund, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.640292 · Cited by 90
The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36
Febbraio, M., Guy, E. C., Coburn, C. T., Knapp, F. F., Beets, A. L., Abumrad, N. A., & Silverstein, R. L. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020515210972 · Cited by 89
Self-citationCardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery
Nagendran, J., Pulinilkunnil, T., Kienesberger, P. C., Sung, M. M. Y., Fung, D., Febbraio, M., & Dyck, J. R. B. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.020 · Cited by 82
Self-citationCD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis
Clugston, R. D., Yuen, J. J., Hu, Y., Abumrad, N. A., Berk, P. D., Goldberg, I. J., Blaner, W. S., & Huang, L. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m041863 · Cited by 82
Dominici, F. P., Cifone, D., Bartke, A., & Turyn, D. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610383 · Cited by 81
GH Does Not Modulate the Early Fasting-Induced Release of Free Fatty Acids in Mice
Steyn, F. J., Leong, J. W., Huang, L., Tan, H. Y., Xie, T. Y., Nelson, C., Waters, M. J., Veldhuis, J. D., Epelbaum, J., & Chen, C. (2012) · Endocrinology · doi:10.1210/en.2011-1681 · Cited by 44
Influence of obesity and body fat distribution on growth hormone kinetics in humans
Langendonk, J. G., Meinders, A. E., Burggraaf, J., Frölich, M., Roelen, C. A. M., Schoemaker, R. C., Cohen, A. F., & Pijl, H. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e824 · Cited by 44
Wilson, C. G., Schupp, M., Burkhardt, B. R., Wu, J., Young, R., & Wolf, B. A. (2010) · Endocrinology · doi:10.1210/en.2010-0379 · Cited by 39
Self-citation
Cited by
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
Triglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170012 · Cited by 1,016
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada, P., González-Rodríguez, Á., García-Monzón, C., & Valverde, Á. M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03003-w · Cited by 518
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Metadata
- Authors
- Wilson, C. G., Tran, J. L., Erion, D. M., Vera, N. B., Febbraio, M., & Weiss, E. J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2015-12-09
- Volume
- 157
- Issue
- 2
- Pages
- 570-585
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2193344030
- Cited by
- 463
- References
- 44
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.